Cargando…
Proteomic profiling of circulating plasma exosomes reveals novel biomarkers of Alzheimer’s disease
BACKGROUND: Neuronal- and astrocyte-derived exosomes have been identified as an optimal source for screening biomarkers for Alzheimer’s disease (AD). However, few studies focus on the bulk exosome population isolated from plasma of AD. This study investigated whether proteins in bulk exosomes can ai...
Autores principales: | Cai, Huimin, Pang, Yana, Wang, Qi, Qin, Wei, Wei, Cuibai, Li, Ying, Li, Tingting, Li, Fangyu, Wang, Qigeng, Li, Yan, Wei, Yiping, Jia, Longfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720984/ https://www.ncbi.nlm.nih.gov/pubmed/36471423 http://dx.doi.org/10.1186/s13195-022-01133-1 |
Ejemplares similares
-
Blood neuro‐exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage
por: Jia, Longfei, et al.
Publicado: (2020) -
Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer’s disease
por: Jia, Longfei, et al.
Publicado: (2021) -
A metabolite panel that differentiates Alzheimer's disease from other dementia types
por: Jia, Longfei, et al.
Publicado: (2021) -
Detection of plasma Aβ seeding activity by a newly developed analyzer for diagnosis of Alzheimer’s disease
por: Jia, Jianping, et al.
Publicado: (2022) -
Plasma biomarkers predict Alzheimer’s disease before clinical onset in Chinese cohorts
por: Cai, Huimin, et al.
Publicado: (2023)